Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: Implications for use of synovial sublining macrophages as a biomarker
Carla A. Wijbrandts(Amsterdam UMC Location University of Amsterdam), Paul P. Tak(Amsterdam UMC Location University of Amsterdam), Jasper J. Haringman(Isala), Daniëlle M. Gerlag(UCB Pharma (United Kingdom)), Tom Smeets(Tilburg University), Clarissa E. Vergunst(Amsterdam UMC Location University of Amsterdam)
Cited by 114
Related Papers
NF-κB: a key role in inflammatory diseases
|Journal of Clinical Investigation|2001|3.9k
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
|Pharmacology & Therapeutics|2007|1.6k
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
|Nature Genetics|2010|1.3k
Common variants at CD40 and other loci confer risk of rheumatoid arthritis
|Nature Genetics|2008|542
Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis
|Annals of the Rheumatic Diseases|2004|464